These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 11362892)

  • 1. The debate on FDA reform: a view from the U.S. Senate. Food and Drug Administration.
    Baker R
    BETA; 1995 Sep; ():41-4. PubMed ID: 11362892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA reform: new Senate bill. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Nov; (no 235):7-8. PubMed ID: 11363048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA reform in Congress: FDA's concerns. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 245):5-7. PubMed ID: 11363624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growing debate over FDA reform. Food and Drug Administration.
    Link D
    GMHC Treat Issues; 1996 Jan; 10(1):1-5. PubMed ID: 11363372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA reform sails through Congress. Food and Drug Administration.
    Link D
    GMHC Treat Issues; 1997 Oct; 11(10):11-2. PubMed ID: 11364819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
    Lietzan E
    J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA reform signed into law. Food and Drug Administration.
    James JS
    AIDS Treat News; 1997 Dec; (No 284):6-7. PubMed ID: 11364915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA revamps committee conflict-of-interest rules.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Oct; 98(19):1354-5. PubMed ID: 17018777
    [No Abstract]   [Full Text] [Related]  

  • 13. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparency.
    Hwang TJ; Avorn J; Carpenter D; Kesselheim AS
    Health Aff (Millwood); 2014 Feb; 33(2):309-15. PubMed ID: 24493775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. Secretary of Labor Robert Reich urges Senate lawmakers to undertake OSHA reform.
    Reich R
    Health Facil Manage; 1994 Jul; 7(7):27. PubMed ID: 10134907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importing a change in diet: the proposed food safety law of 2010 and the possible impact on importers and international trade.
    May SG
    Food Drug Law J; 2010; 65(1):1-35, i. PubMed ID: 24475533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA policy on unapproved drug products: past, present, and future.
    Chhabra R; Kremzner ME; Kiliany BJ
    Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.
    Chambers JD; May KE; Neumann PJ
    Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.